The DOI matches its Crossref record; 329 of the 329 references it cites were found in a registry or an index.
CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
Open accessAbstract
The cancer stem cell (CSC) hypothesis, despite the limitations of the currently available models and assays, has ushered in a new era of excitement in cancer research. The development of novel strategies for anti‐tumour therapy relies on the use of biomarkers to identify, enrich, and/or isolate the cell population(s) of interest. In this context, various cell characteristics and antigen expression profiles are discussed as surrogate markers. The cell surface expression of the human prominin‐1 (CD133) antigen, in particular of the AC133 epitope, is among those that have been most frequently studied in solid cancers, although no mechanism has yet been proposed to link CD133 expression with the CSC phenotype. Some inconsistencies between published data can be ascribed to different analytical tools as well as methodological limitations and pitfalls, highlighted in the present review. Therefore, a comprehensive overview on the current state of knowledge in this growing and exciting field with an emphasis on the most recent studies is presented. We highlight the link between the tumour microenvironment, tumour cell plasticity, and CD133 expression, and evaluate the utility of CD133 expression as a prognostic marker. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–329 of 329
Cancer stem cells and their niche
Iwasaki, H., & Suda, T. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01177.x · Cited by 142
Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential
Heddleston, J. M., Wu, Q., Rivera, M., Minhas, S., Lathia, J. D., Sloan, A. E., Iliopoulos, O., Hjelmeland, A. B., & Rich, J. N. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.109 · Cited by 142
Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2
Suzuki, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1207 · Cited by 141
mTOR Signal and Hypoxia-Inducible Factor-1α Regulate CD133 Expression in Cancer Cells
MATSUMOTO, K. Y., Arao, T., Tanaka, K., Kaneda, H., Kudo, K., Fujita, Y., Tamura, D., Aomatsu, K., Tamura, T., Yamada, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1289 · Cited by 140
Pathological Society of Great Britain and Ireland
McCance, D. J. (1984) · Journal of Medical Microbiology · doi:10.1099/00222615-18-3-438 · Cited by 139
The Stem Cell Marker CD133 (Prominin-1) Is Expressed in Various Human Glandular Epithelia
Karbanová, J., Missol‐Kolka, E., Fonseca, A., Lorra, C., Janich, P., Hollerová, H., Jászai, J., Ehrmann, J., Kolář, Z., Liebers, C., et al. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.951897 · Cited by 137
Self-citationCD133 expression associated with poor prognosis in ovarian cancer
Zhang, J., Guo, X. Q., Chang, D. Y., Rosen, D. G., Mercado‐Uribe, I., & Liu, J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.170 · Cited by 137
Jaksch, M., Múnera, J. O., Bajpai, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0723 · Cited by 137
Chemokine Networks and Breast Cancer Metastasis
Karnoub, A. E., & Weinberg, R. A. (2007) · Breast Disease · doi:10.3233/bd-2007-26107 · Cited by 136
Phenotypes of stem cells from diverse origin
Tárnok, A., Ulrich, H., & Bocsi, J. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20844 · Cited by 136
Yan, X. S., Ma, L., Yi, D., Yoon, J.-G., Diercks, A. H., Foltz, G., Price, N. D., Hood, L., & Tian, Q. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018696108 · Cited by 130
The Lymphovascular Embolus of Inflammatory Breast Cancer Expresses a Stem Cell-Like Phenotype
Xiao, Y. Q., Ye, Y., Yearsley, K. H., Jones, S., & Barsky, S. H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071214 · Cited by 128
Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells
Du, Z., Qin, R., Wei, C., Wang, M., Shi, C., Tian, R., & Peng, C. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1340-0 · Cited by 127
Schulte, A., Günther, H. S., PHILLIPS, H. S., Kemming, D., Martens, T., Kharbanda, S., Soriano, R. H., Modrusan, Z. D., Zapf, S., Westphal, M., et al. (2011) · Glia · doi:10.1002/glia.21127 · Cited by 127
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
Orzan, F., Pellegatta, S., Poliani, P. L., Pisati, F., Caldera, V., Menghi, F., Kapetis, D., Marras, C. E., Schiffer, D., & Finocchiaro, G. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01132.x · Cited by 126
How powerful is CD133 as a cancer stem cell marker in brain tumors?
Cheng, J., Liu, B.-L., & Zhang, X. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.03.002 · Cited by 126
Fargeas, C. A., Joester, A., Missol‐Kolka, E., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01315 · Cited by 126
Self-citationEffects of Carbon Ion Beam on Putative Colon Cancer Stem Cells and Its Comparison with X-rays
Cui, X., Oonishi, K., Tsujii, H., Yasuda, T., Matsumoto, Y., Furusawa, Y., Akashi, M., Kamada, T., & Okayasu, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2926 · Cited by 124
Tumor-associated fibroblasts (part II): Functional impact on tumor tissue.
Kunz‐Schughart, L. A., & Knuechel, R. (2002) · PubMed · doi:10.14670/hh-17.623 · Cited by 124
Self-citationLimits of CD133 as a marker of glioma self‐renewing cells
Clément, V., Dutoit, V., Marino, D., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24352 · Cited by 121
Rebetz, J., Tian, D., Persson, A., Widegren, B., Salford, L. G., Englund, E. M., Gisselsson, D., & Fan, X. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001936 · Cited by 119
Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/ Rhabdoid Tumor
Chiou, S., Kao, C.-L., Chen, Y., Chien, C., Hung, S., Lo, J., Chen, Y.-J., Ku, H., Hsu, M., & Wong, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002090 · Cited by 118
Chen, Y., Wu, M., Huang, C., Lin, S., Chuang, T., Yu, C.-C., & Lo, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028053 · Cited by 116
Sequential expression of putative stem cell markers in gastric carcinogenesis
Wang, T., Ong, C. W., Shi, J., Srivastava, S., Yan, B., Cheng, C. L., Yong, W. P., Chan, S. L., Yeoh, K. G., Iacopetta, B. M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.287 · Cited by 115
Bauer, N., Wilsch‐Bräuninger, M., Karbanová, J., Fonseca, A., Strauss, D., Freund, D., Thiele, C., Huttner, W. Β., Bornhäuser, M., & Corbeil, D. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100147 · Cited by 115
Self-citationRe-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes
Chen, T. R. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000132579 · Cited by 114
Hsu, H., Huang, P., Chang, Y., Tzao, C., Chen, Y., Shih, H., Hung, S., Chen, Y., Tseng, L., & Chiou, S. (2011) · Cancer · doi:10.1002/cncr.25869 · Cited by 113
Fargeas, C. A., Corbeil, D., & Huttner, W. Β. (2003) · Stem Cells · doi:10.1634/stemcells.21-4-506 · Cited by 113
Self-citationSundberg, M., Jansson, L., Ketolainen, J. M., PIHLAJAMÄKI, H. K., Suuronen, R., Skottman, H., Inzunza, J., Hovatta, O., & Narkilahti, S. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.08.001 · Cited by 112
Becker, L. S., Huang, Q. M., & Mashimo, H. L. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.148 · Cited by 112
Promoter hypomethylation regulates CD133 expression in human gliomas
Tabu, K., Sasai, K., Kimura, T., Wang, L., Aoyanagi, E., Kohsaka, S., Tanino, M. A., Nishihara, H., & Tanaka, S. (2008) · Cell Research · doi:10.1038/cr.2008.270 · Cited by 109
Hashimoto, O., Shimizu, K., Semba, S., Chiba, S., Ku, Y., Yokozaki, H., & Hori, Y. (2011) · Pathobiology · doi:10.1159/000325538 · Cited by 108
Targeting CD133 antigen in cancer
Ferrandina, G., Petrillo, M., Bonanno, G., & Scambia, G. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903005616 · Cited by 107
Nomenclature of prominin‐1 (CD133) splice variants – an update
Fargeas, C. A., Huttner, W. Β., & Corbeil, D. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00825.x · Cited by 107
Self-citationCD133 identifies perivascular niches in grade II–IV astrocytomas
Christensen, K. G., Schrøder, H. D., & Kristensen, B. W. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9648-8 · Cited by 106
Elsaba, T. M., Martínez‐Pomares, L., Robins, A., Crook, S., Seth, R., Jackson, D., Reed, A. E. M., Silver, A. R., Tomlinson, I. P. M., & Ilyas, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010714 · Cited by 104
Li, C.-Y., Li, B.-X., Liang, Y., Peng, R.-Q., Ding, Y., Xu, D.-Z., Zhang, X., Wan, D.-S., Wan, D. S., Zeng, Y.-X., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-56 · Cited by 102
Zen, C., Zen, Y., Mitry, R. R., Corbeil, D., Karbanová, J., O’Grady, J., Karani, J. B., Kane, P., Heaton, N. D., Portmann, B. C., et al. (2011) · Liver Transplantation · doi:10.1002/lt.22314 · Cited by 101
Self-citationCorbeil, D., Röper, K., Weigmann, A., & Huttner, W. Β. (1998) · Blood · doi:10.1182/blood.v91.7.2625 · Cited by 95
Self-citationBoman, B. M., Wicha, M. S., Fields, J. Z., & Runquist, O. A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100202 · Cited by 95
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line
Xu, W. D., Zhou, L. F., Cheng, L., Tian, J., Jiang, J. J., & MacCallum, J. K. (2008) · Head & Neck · doi:10.1002/hed.20935 · Cited by 95
Kusumbe, A. P., Mali, A. M., & Bapat, S. A. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0868 · Cited by 94
Cancer Stem Cells as a Predictive Factor in Radiotherapy
Brunner, T. B., Kunz‐Schughart, L. A., Grosse‐Gehling, P., & Baumann, M. A. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2011.12.003 · Cited by 93
Self-citationHuttner, H. B., Janich, P., Köhrmann, M., Jászai, J., Siebzehnrübl, F. A., Blümcke, I., Suttorp, M., Gahr, M. L., Kuhnt, D., Nimsky, C., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0639 · Cited by 91
Self-citationCancer stem cells and radiotherapy
Baumann, M. A., Krause, M., Thames, H. D., et al. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902836404 · Cited by 91
Computer modeling implicates stem cell overproduction in colon cancer initiation.
Boman, B. M., Fields, J. Z., Bonham-Carter, O., & Runquist, O. A. (2001) · PubMed · Cited by 90
Feldman, D. E., Chen, C., Punj, V., Tsukamoto, H., & Machida, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114438109 · Cited by 90
Stem Cell Marker Prominin-1/AC133 Is Expressed in Duct Cells of the Adult Human Pancreas
Lardon, J., Corbeil, D., Huttner, W. Β., Ling, Z., & Bouwens, L. (2008) · Pancreas · doi:10.1097/mpa.0b013e318149f2dc · Cited by 90
Self-citationPluripotency Associated Genes Are Reactivated by Chromatin-Modifying Agents in Neurosphere Cells
Ruau, D., Enseñat‐Waser, R., Dinger, T. C., Vallabhapurapu, D. S., Rolletschek, A., Hacker, C., Hieronymus, T., Wobus, A. M., Müller, A. M., & Zenke, M. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0649 · Cited by 89
Boivin, D., Labbé, D. P., Fontaine, N., Lamy, S., Beaulieu, É., Gingras, D., & Béliveau, R. (2009) · Biochemistry · doi:10.1021/bi900159d · Cited by 88
Hermansen, S. K., Christensen, K. G., Jensen, S. S., & Kristensen, B. W. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411400867 · Cited by 88
Glycan changes: cancer metastasis and anti-cancer vaccines
Li, M., Song, L., & Qin, X. (2010) · Journal of Biosciences · doi:10.1007/s12038-010-0073-8 · Cited by 88
Lin, E. H., Hassan, M. M., Li, Y., Zhao, H., Nooka, A. K., Sorenson, E., Xie, K., Champlin, R., Wu, X., & Li, D. (2007) · Cancer · doi:10.1002/cncr.22774 · Cited by 86
Pilati, P., D, S. M. M., Bertazza, L., Galdi, F., Briarava, M., Mammano, E., Tessari, E., Zavagno, G., & Nitti, D. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2132-2 · Cited by 82
Galizia, G., Gemei, M., Vecchio, L. D., Zamboli, A. G. I., Noto, R. D., Mirabelli, P., Salvatore, F., Castellano, P., Orditura, M., Vita, F. D., et al. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.795 · Cited by 81
Complex genetic regulation of proteinglycosylation
Lauc, G., Rudan, I., Campbell, H. J., & Rudd, P. M. (2009) · Molecular BioSystems · doi:10.1039/b910377e · Cited by 80
Dittfeld, C., Dietrich, A., Peickert, S., Hering, S., Baumann, M. A., Grade, M., Ried, T., & Kunz‐Schughart, L. A. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.034 · Cited by 80
Self-citationHorst, D. A., Kriegl, L., Engel, J., Jung, A., & Kirchner, T. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.004 · Cited by 74
Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro
Mihatsch, J., Toulany, M., Bareiss, P. M., Grimm, S., Lengerke, C., Kehlbach, R., & Rodemann, H. P. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.003 · Cited by 73
Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer
Wang, Q., Chen, Z., Chang-zhen, D., Wang, H., Yan, L., & Gu, J. F. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03378.x · Cited by 73
Novel germ cell markers characterize testicular seminoma and fetal testis
Gashaw, I., Dushaj, O., Behr, R., Biermann, K., Brehm, R., Rubben, H., Grobholz, R., Schmid, K. W., Bergmann, M. M., & Winterhager, E. (2007) · Molecular Human Reproduction · doi:10.1093/molehr/gam059 · Cited by 73
Epigenetic Landscaping During hESC Differentiation to Neural Cells
Golebiewska, A., Atkinson, S. P., Lako, M., & Armstrong, L. (2009) · Stem Cells · doi:10.1002/stem.59 · Cited by 72
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
Artells, R., Moreno, I., Díaz, T., Martínez, F., Gel, B., Navarro, A., Ibeas, R., Moreno, J., & Monzó, M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.11.003 · Cited by 71
Peh, G. S. L., Lang, R. J., Pera, M. F., & Hawes, S. M. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0124 · Cited by 70
Annabi, B., Lachambre, M., Plouffe, K., Sartelet, H., & Béliveau, R. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20541 · Cited by 70
Tabu, K., Kimura, T., Sasai, K., Wang, L., Bizen, N., Nishihara, H., Taga, T., & Tanaka, S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-39 · Cited by 70
Insight into the complex regulation of CD133 in glioma
Campos, B., & Herold‐Mende, C. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25687 · Cited by 69
Rocco, A., Liguori, E., Pirozzi, G., Tirino, V., Compare, D., Franco, R., Tatangelo, F., Palaia, R., D’Armiento, F. P., Pollastrone, G., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23013 · Cited by 69
Differential role of CD133 and CXCR4 in renal cell carcinoma
D’Alterio, C., Cindolo, L., Portella, L., Polimeno, M., Consales, C., Riccio, A., Cioffi, M., Franco, R., Chiodini, P., Cartenì, G., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.22.13680 · Cited by 69
Xi, H., & Zhao, P. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.087213 · Cited by 65
Marzesco, A., Wilsch‐Bräuninger, M., Dubreuil, V., Janich, P., Langenfeld, K., Thiele, C., Huttner, W. Β., & Corbeil, D. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.048 · Cited by 64
Self-citationComparative genomics on PROM1 gene encoding stem cell marker CD133
Katoh, Y., & Katoh, M. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.6.967 · Cited by 63
Glioma-initiating cells and molecular pathology: implications for therapy
Natsume, A., Kinjo, S., Yuki, K., Kato, T., Ohno, M., Motomura, K., Iwami, K., & Wakabayashi, T. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-010-0011-3 · Cited by 62
Métellus, P., Nanni‐Metellus, I., Delfino, C., Colin, C., Tchogandjian, A., Coulibaly, B., Fina, F., Loundou, A., Barrie, M., Chinot, O. L., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1703-6 · Cited by 61
Margolin, D. A., Silinsky, J., Grimes, C., Spencer, N. D., Aycock, M., Green, H., Cordova, J., Davis, N. K., Driscoll, T., & Li, L. (2011) · Neoplasia · doi:10.1593/neo.11324 · Cited by 60
Hemmoranta, H., Satomaa, T., Blomqvist, M., Heiskanen, A., Aitio, O., Saarinen, J., Natunen, J., Partanen, J., Laine, J. T., & Jaatinen, T. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.05.006 · Cited by 60
Liang, Y., Zhou, Z.-H., Ping, Y., Chen, J., Yao, X., Feng, H., Lu, J.-Y., Wang, J. M., & Bian, X. (2007) · Modern Pathology · doi:10.1038/modpathol.3800942 · Cited by 60
The Effect of Lethally Irradiated Cells on the Transplantability of Murine Tumours
Hewitt, H. B., Blake, E. R., & Porter, E. H. (1973) · British Journal of Cancer · doi:10.1038/bjc.1973.130 · Cited by 60
Tseng, L., Huang, P., Chen, Y.-R., Chen, Y., Chou, Y.-C., Chen, Y., Chang, Y.-L., Hsu, H., Lan, Y., Chen, K.-H., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188730 · Cited by 60
2,3-Sialylation regulates the stability of stem cell marker CD133
Zhou, F., Cui, C., Ge, Y., Chen, H., Li, Q., Yang, Z., Wu, G. C., Sun, S., Chen, K., Gu, J., et al. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq062 · Cited by 59
Shao, C., Fu, Y., Lu, W., & Fan, X. (2010) · Cells Tissues Organs · doi:10.1159/000319797 · Cited by 58
Friel, A. M., Zhang, L., Curley, M. D., Therrien, V. A., Sergent, P. A., Belden, S. E., Borger, D. R., Mohapatra, G., Zukerberg, L. R., Foster, R., et al. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-147 · Cited by 58
Expression of distinct splice variants of the stem cell marker prominin‐1 (CD133) in glial cells
Corbeil, D., Joester, A., Fargeas, C. A., Jászai, J., Garwood, J., Hellwig, A., Werner, H. B., & Huttner, W. Β. (2008) · Glia · doi:10.1002/glia.20812 · Cited by 58
Self-citationIdentification of tumorigenic retinal stem‐like cells in human solid retinoblastomas
Zhong, X., Li, Y., Peng, F., Huang, B. Q., Lin, J., Zhang, W., Zheng, J., Jiang, R., Song, G., & Ge, J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22880 · Cited by 57
Smith, S. J., Tilly, H., Ward, J. H., Macarthur, D., Lowe, J. S., Coyle, B., & Grundy, R. G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0952-1 · Cited by 57
Kai, K., Nagano, O., Sugihara, E., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01318.x · Cited by 55
Systems glycobiology: biochemical reaction networks regulating glycan structure and function
Neelamegham, S., & Liu, G. (2011) · Glycobiology · doi:10.1093/glycob/cwr036 · Cited by 53
Targeting colorectal cancer stem cells with inducible caspase-9
Kemper, K., Rodermond, H. M., Çolak, S., Grandela, C., & Medema, J. P. (2012) · APOPTOSIS · doi:10.1007/s10495-011-0692-z · Cited by 52
CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells
Chao, C., Carmical, J. R., Ives, K. L., Wood, T. G., Aronson, J. F., Gomez, G. A., Djukom, C. D., & Hellmich, M. R. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.185 · Cited by 51
Tanaka, H. (2009) · Oncology Reports · doi:10.3892/or_00000491 · Cited by 51
King, F. W., Ritner, C., Liszewski, W. J., Kwan, H. C. K., Pedersen, A., Leavitt, A. D., & Bernstein, H. S. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0012 · Cited by 50
Rebetz, J., Tian, D., Persson, A., Widegren, B., Salford, L. G., Englund, E. M., Nord, D. G., & Fan, X. (2008) · Cited by 50
Ding, Q., Yoshimitsu, M., Kuwahata, T., Maeda, K., Hayashi, T., Obara, T., Miyazaki, Y., Matsubara, S., Natsugoe, S., & Takao, S. (2011) · Human Cell · doi:10.1007/s13577-011-0037-9 · Cited by 49
Serikov, V. B., Hounshell, C., Larkin, S. K., Green, W., Ikeda, H., Walters, M. C., & Kuypers, F. A. (2009) · Experimental Biology and Medicine · doi:10.3181/0809-bc-262 · Cited by 48
Expression and regulation of AC133 and CD133 in glioblastoma
Campos, B., Zeng, L., DaoTrong, P. H., Eckstein, V., Unterberg, A. W., Mairbäurl, H., & Herold‐Mende, C. C. (2011) · Glia · doi:10.1002/glia.21239 · Cited by 48
Saigusa (2010) · Oncology Reports · doi:10.3892/or_00000865 · Cited by 47
Differential Membrane Proteomics Using 18O-Labeling To Identify Biomarkers for Cholangiocarcinoma
Kristiansen, T. Z., Gowda, H., Grønborg, M., Maitra, A., & Pandey, A. (2008) · Journal of Proteome Research · doi:10.1021/pr800215n · Cited by 46
Hałasa, M., Baśkiewicz‐Masiuk, M., Dąbkowska, E., & Machaliński, B. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0036-1 · Cited by 46
SURROGATE MARKERS PREDICT ANGIOGENIC POTENTIAL AND SURVIVAL IN PATIENTS WITH GLIOBLASTOMA MULTIFORME
Greenfield, J. P., Jin, D. K., Young, L. M., Christos, P. J., Abrey, L. E., Rafii, S., & Gutin, P. H. (2009) · Neurosurgery · doi:10.1227/01.neu.0000343742.06625.db · Cited by 44
Induction of cytotoxic T lymphocytes against ovarian cancer‐initiating cells
Weng, D., Song, B., Durfee, J., Sugiyama, V. E., Wu, Z., Koido, S., Calderwood, S. K., & Gong, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25851 · Cited by 44
Liebertz, D. J., Lechner, M. G., Masood, R., Sinha, U. K., Han, J., Puri, R. K., Correa, A. J., & Epstein, A. L. (2010) · Head & Neck Oncology · doi:10.1186/1758-3284-2-5 · Cited by 44
Majka, S. M., Skokan, M. C., Wheeler, L., Harral, J. W., Gladson, S., Burnham, E. L., Loyd, J. E., Stenmark, K. R., Varella‐Garcia, M., & West, J. D. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90449.2008 · Cited by 44
Nikolova, T., Wu, M., Brumbarov, K., Alt, R., Opitz, H., Boheler, K. R., Cross, M. A., & Wobus, A. M. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00119.x · Cited by 43
Guo, A., & Jahoda, C. A. B. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00900.x · Cited by 43
Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells
Chen, K.-H., Hsu, C. C., Song, W.-S., Huang, C. S., Tsai, C.-C., Kuo, C., Hsu, H., Tsai, T., Tsai, C. Y., Woung, L., et al. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1190-2 · Cited by 42
Raso, A., Mascelli, S., Biassoni, R., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor022 · Cited by 40
CD133+adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF)
Carter, D. A., Dick, A. D., & Mayer, E. J. (2009) · BMC Ophthalmology · doi:10.1186/1471-2415-9-1 · Cited by 40
Tchaicha, J. H., Mobley, A. K., Hossain, M. G., Aldape, K., & McCarty, J. H. (2010) · Oncogene · doi:10.1038/onc.2010.199 · Cited by 40
Mesenchymal Stromal Cells Can Be Derived From Bone Marrow CD133 + Cells: Implications for Therapy
Pozzobon, M., Piccoli, M., Ditadi, A., Bollini, S., Destro, R., André‐Schmutz, I., Masiero, L., Lenzini, E., Zanesco, L., Petrelli, L., et al. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0003 · Cited by 38
Progress in understanding melanoma propagation
Shackleton, M. J., & Quintana, E. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.006 · Cited by 36
Lin, J., Zhang, X., Yang, J., Ye, Y.-B., & Luo, S.-Q. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.10.006 · Cited by 35
Zhou, J., Wang, H., Cannon, V. S., Wolcott, K., Song, H., & Yates, C. C. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-112 · Cited by 34
Dittfeld, C., Dietrich, A., Peickert, S., Hering, S., Baumann, M. A., Grade, M., Ried, T., & Kunz‐Schughart, L. A. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.10.010 · Cited by 34
Self-citationCD133 expression in rectal cancer after preoperative chemoradiotherapy
Kojima, M., Ishii, G., Atsumi, N., Nishizawa, Y., Saito, N., & Ochiai, A. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01478.x · Cited by 29
McDonald, S. A. C., Graham, T. A., Schier, S., Wright, N. A., & Alison, M. R. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0783-1 · Cited by 29
Self-citationCui, L., Ohuchida, K., Mizumoto, K., Moriyama, T., Onimaru, M., Nakata, K., Nabae, T., Ueki, T., Sato, N., Tominaga, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012121 · Cited by 29
Mobilization of very small embryonic-like stem cells in acute coronary syndromes and stroke
Wojakowski, W., Ratajczak, M. Z., & Tendera, M. (2010) · Herz · doi:10.1007/s00059-010-3389-0 · Cited by 27
Promoter hypermethylation and loss ofCD133gene expression in colorectal cancers
Jeon, Y.-K. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i25.3153 · Cited by 25
García, V. M., Batlle, J. F., Casado, E., Burgos, E., de Castro, J., Belda-Iniesta, C., Barriuso, J., Sánchez, J. J., García‐Cabezas, M. Á., González‐Barón, M., et al. (2010) · Colorectal Disease · doi:10.1111/j.1463-1318.2010.02386.x · Cited by 24
Mariotti, E., Gemei, M., Mirabelli, P., D’Alessio, F., Noto, R. D., Fortunato, G., & Vecchio, L. D. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-120 · Cited by 24
Human Mesenchymal Stem Cells Form Multicellular Structures in Response to Applied Cyclic Strain
Doyle, A. M., Nerem, R. M., & Ahsan, T. (2009) · Annals of Biomedical Engineering · doi:10.1007/s10439-009-9644-y · Cited by 22
Genome and Transcriptome Profiles of CD133-Positive Colorectal Cancer Cells
Gaiser, T., Camps, J., Meinhardt, S., Wangsa, D., Nguyen, Q. T., Varma, S., Dittfeld, C., Kunz‐Schughart, L. A., Kemmerling, R., Becker, M. R., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.036 · Cited by 22
Self-citationRapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo
Peickert, S., Waurig, J., Dittfeld, C., Dietrich, A., Garbe, Y., Kabus, L., Baumann, M. A., Grade, M., Ried, T., & Kunz‐Schughart, L. A. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.124 · Cited by 17
Self-citationRussell, S. M., Lechner, M. G., Gong, L., et al. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.05.015 · Cited by 14
Xu, Y., Hu, Y., Zhou, J., & Zhang, M. (2010) · Cell Biology International · doi:10.1042/cbi20100473 · Cited by 11
Diabetes-relevant regulation of cultured blood outgrowth endothelial cells
Wang, S., & Hirschberg, R. R. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.06.002 · Cited by 10
Divergent expression of CD133 in different studies on HCT‐116 cell line
Gemei, M., Mirabelli, P., Noto, R. D., Fortunato, G., & Vecchio, L. D. (2010) · International Journal of Cancer · doi:10.1002/ijc.25406 · Cited by 7
Wang, J., Li, F., Zhang, G., Chen, Y., Hu, Y., Chen, X., Lu, B., & Zhang, X. (2010) · Hybridoma · doi:10.1089/hyb.2009.0113 · Cited by 5
(2003) · PubMed
Cited by
Unravelling cancer stem cell potential
Beck, B., & Blanpain, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3597 · Cited by 905
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., et al. (2014) · Nature · doi:10.1038/nature13305 · Cited by 656
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Cancer stem cell surface markers on normal stem cells
Kim, W.-T., & Ryu, C. J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.6.039 · Cited by 332
Mesothelial Cells Facilitate Cancer Stem like properties in spheroids of ovarian cancer cells
Shishido, A., Mori, S., Yokoyama, Y., Hamada, Y., Minami, K., Qian, Y., Wang, J., Hirose, H., Wu, X., Kawaguchi, N., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6605 · Cited by 34
Metadata
- Authors
- Grosse‐Gehling, P., Fargeas, C. A., Dittfeld, C., Garbe, Y., Alison, M. R., Corbeil, D., & Kunz‐Schughart, L. A.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2012-11-20
- Volume
- 229
- Issue
- 3
- Pages
- 355-378
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2166424982
- Cited by
- 301
- References
- 329
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.